Company Encyclopedia
View More
name
Chengzhi
000990.SZ
Chengzhi Co., Ltd. engages in the clean energy, semiconductor display material, medical healthcare, and life science businesses in China. The company produces and sells gas products, including carbon monoxide, syngas, butane, isobutanal, ethane, propane, crude benzene, ethylene, hydrogen, propylene, methanol, butylene glycol, Butanoctyl, diolefin, and other chemicals. It also produces and sells life science and technology products, such as D-ribose and industrial hemp.
3.135 T
000990.SZMarket value -Rank by Market Cap -/-

Financial Score

06/12/2025 Update
C
Commodity ChemicalsIndustry
Industry Ranking133/271
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE0.65%D
    • Profit Margin1.00%C
    • Gross Margin16.50%D
  • Growth ScoreC
    • Revenue YoY8.41%B
    • Net Profit YoY-56.36%D
    • Total Assets YoY2.68%C
    • Net Assets YoY0.51%C
  • Cash ScoreB
    • Cash Flow Margin9966.11%A
    • OCF YoY8.41%B
  • Operating ScoreC
    • Turnover0.42C
  • Debt ScoreB
    • Gearing Ratio31.67%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Guo Tai Epoint Software Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025

    Guo Tai Epoint Software Co.,Ltd reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 1,052.65 million compared to CNY 1,257.96 million a year ago. Net loss was CNY 106.63 million compared to CNY 13.89 million a year ago.Basic loss per share from continuing operations was CNY 0.33 compared to CNY 0.04 a year ago. Diluted loss per share from continuing operations was CNY 0.33 compared to CNY 0.04 a year ago.

    marketscreener·
    SH
    688232
    +2.07%
    marketscreener·
    SH
    688232
    +2.07%

    Chengzhi released its performance for the first three quarters, with a net profit attributable to the parent company of 104 million yuan, a year-on-year decrease of 52.58%

    According to the Zhitong Finance APP, Chengzhi released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 8.704 billion yuan, a year-on-year increase of 5.66%. The net profit attributable to shareholders of the listed company was 104 million yuan, a year-on-year decrease of 52.58%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 113 million yuan, a year-on-year decrease of 41.34%

    Zhitong·
    SZ
    000990
    +2.13%
    Zhitong·
    SZ
    000990
    +2.13%

    Chengzhi: The net profit for the third quarter was 84.4545 million yuan, a year-on-year increase of 169.63%

    Chengzhi announced that the revenue for the third quarter was 2.723 billion yuan, a year-on-year increase of 5.68%; the net profit was 84.4545 million yuan, a year-on-year increase of 169.63%. The revenue for the first three quarters was 8.704 billion yuan, a year-on-year increase of 5.66%; the net profit was 104 million yuan, a year-on-year decrease of 52.58%

    Zhitong·
    SZ
    000990
    +2.13%
    Zhitong·
    SZ
    000990
    +2.13%

    Chengzhi: The company's D-ribose can be used as a starting material for some innovative drugs

    On August 13th, Chengzhi stated on the interactive platform that the company's D-ribose can be used as a starting material for some innovative drugs

    Zhitong·
    SZ
    000990
    +2.13%
    Zhitong·
    SZ
    000990
    +2.13%

    Industrial hemp concept stocks opened strong, with Rhine Biotech hitting the daily limit

    Rhein Biotech hit the daily limit, Fuan Pharmaceutical and CCGB rose over 5%, while Yongji Co., Ltd., Dezhan Health, Chengzhi, and Kang En Bei also followed suit

    Zhitong·
    SZ
    000990
    +2.13%
    SZ
    300194
    -0.86%
    SZ
    300138
    +1.65%
    Zhitong·
    SZ
    000990
    +2.13%
    SZ
    300194
    -0.86%
    SZ
    300138
    +1.65%
    © 2025 Longbridge｜Disclaimer